Security Snapshot

Prenetics Global Ltd - Class A Ordinary Shares, par value $0.0015 per share (PRE) Institutional Ownership

CUSIP: G72245122

13F Institutional Holders and Ownership History from Q4 2023 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

33

Shares (Excl. Options)

1,990,402

Price

$19.32

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+268,256
Value change
+$5,908,593
Number of holders
33
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
14,813,848
SEC-reported price per share
$20.18
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • PRE - Prenetics Global Ltd - Class A Ordinary Shares, par value $0.0015 per share is tracked under CUSIP G72245122.
  • 33 institutions reported positions in Q1 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 32 to 33 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $27,401,264 to $38,455,032.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 33 institutions filings for Q1 2026.

Open SEC evidence

Security key

G72245122

Latest holder period

Q1 2026

13F holders

33

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
PRE
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Genetel Bioventures Ltd 3.3% $9,444,962 488,857 Genetel Bioventures Ltd 31 Mar 2026
EASTSPRING INVESTMENTS (SINGAPORE) LTD 3.8% $2,225,408 427,963 EASTSPRING INVESTMENTS (SINGAPORE) LIMITED 30 Sep 2024

As of 31 Mar 2026, 33 institutional investors reported holding 1,990,402 shares of Prenetics Global Ltd - Class A Ordinary Shares, par value $0.0015 per share (PRE). This represents 13% of the company’s total 14,813,848 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
13%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
PRUDENTIAL PLC 2.9% 427,963 0% 0.06% $8,268,245
Aspex Management (HK) Ltd 2.3% 346,150 0% 0.1% $6,688,000
Tenzing Global Management, LLC 1.4% 200,000 3.2% $3,864,000
GOLDMAN SACHS GROUP INC 1.3% 193,583 +358% 0% $3,740,024
MILLENNIUM MANAGEMENT LLC 1.3% 192,600 +274% 0% $3,721,032
WELLS FARGO & COMPANY/MN 0.57% 84,806 +2727% 0% $1,638,452
NOMURA HOLDINGS INC 0.51% 75,619 -72% 0.01% $1,460,959
MARSHALL WACE, LLP 0.5% 73,332 +47% 0% $1,416,774
JANE STREET GROUP, LLC 0.28% 42,186 -49% 0% $815,034
683 Capital Management, LLC 0.27% 40,000 -47% 0.07% $772,800
XTX Topco Ltd 0.23% 33,417 0.01% $645,616
BlackRock, Inc. 0.22% 33,246 +7% 0% $642,312
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.22% 33,124 0% $639,956
RENAISSANCE TECHNOLOGIES LLC 0.21% 31,322 +85% 0% $605,141
HRT FINANCIAL LP 0.2% 28,943 0% $559,000
STEVENS CAPITAL PARTNERS 0.19% 28,147 +55% 0.13% $543,800
UBS Group AG 0.18% 26,773 +197% 0% $517,255
Hudson Bay Capital Management LP 0.15% 22,253 +19% 0% $429,928
Qube Research & Technologies Ltd 0.13% 19,130 -39% 0% $369,592
MORGAN STANLEY 0.12% 17,093 -28% 0% $330,237
Integrated Quantitative Investments LLC 0.09% 13,602 0.05% $262,791
OMERS ADMINISTRATION Corp 0.08% 11,900 -39% 0% $229,908
Brevan Howard Capital Management LP 0.07% 10,233 0% $197,702
State of Wyoming 0.02% 2,499 0.01% $48,281
IFP Advisors, Inc 0% 649 0% $12,539

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
10
Latest
Q1 2026
Rows shown
1-10 of 10
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 1,990,402 $38,455,032 +$5,908,593 $19.32 33
2025 Q4 1,739,977 $27,401,264 +$6,722,321 $15.75 32
2025 Q3 1,295,941 $17,236,109 +$1,887,610 $13.30 15
2025 Q2 1,154,007 $9,782,769 +$82,255 $8.51 10
2025 Q1 1,149,706 $4,571,132 +$40,846 $3.92 9
2024 Q4 1,139,286 $6,603,908 +$157,350 $5.80 9
2024 Q3 1,112,142 $4,470,372 -$323,702 $4.00 8
2024 Q2 1,192,380 $7,058,681 -$967,203 $5.92 7
2024 Q1 1,355,901 $5,491,493 +$1,931,498 $4.05 8
2023 Q4 879,011 $5,222,346 +$5,222,346 $5.91 5
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .